Multiple myeloma trials in Türkiye
11 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 3RecruitingTrial-stage medicine
A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
- Where
- Ankara, Istanbul, Izmir, Mamak
- Age
- 18 years and over
- People
- 915 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07222761EU 2024-519504-27-00Registry updated 2026-11-04
Phase 3RecruitingTrial-stage medicine
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
- Where
- Ankara, Antalya, Denizli, Istanbul, Izmir, Samsun
- Age
- 18 years and over
- People
- 1,590 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05552222EU 2023-503442-30-00Registry updated 2026-11-03
Phase 3RecruitingTrial-stage medicine
A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not Planned
- Where
- Ankara, Antalya, Istanbul, Izmir, Samsun
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07665450Registry updated 2026-11-03
Phase 3RecruitingTrial-stage medicine
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
- Where
- Ankara, Istanbul, Izmir, Kayseri, Samsun
- Age
- 18 years and over
- People
- 810 worldwide
- Run by
- Celgene
See details and how to joinNCT05519085Registry updated 2026-10-30
Phase 3RecruitingTrial-stage medicine
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
- Where
- Ankara
- Age
- 18 years and over
- People
- 440 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT06615479EU 2024-515279-37-00Registry updated 2026-10-29
Phase 3RecruitingTrial-stage medicine
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
- Where
- Ankara, Istanbul, Izmir, Kayseri
- Age
- 18 years and over
- People
- 1,594 worldwide
- Run by
- European Myeloma Network B.V.
See details and how to joinNCT05243797EU 2023-510384-36-00Registry updated 2026-10-07
Phase 3RecruitingTrial-stage medicine
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Ankara, Antalya, Istanbul, Izmir, Mersin, Samsun
- Age
- 18 years and over
- People
- 700 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07518186Registry updated 2026-09-25
Phase 3RecruitingTrial-stage medicine
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
- Where
- Adana, Ankara, Antalya, Gaziantep, Istanbul, Izmir, Kayseri, Kocaeli, Malatya
- Age
- 18 years and over
- People
- 893 worldwide
- Run by
- Pfizer
See details and how to joinNCT05020236EU 2023-509208-14-00Registry updated 2026-08-24
Phase 1/2RecruitingTrial-stage medicine
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
- Where
- Istanbul, Kayseri
- Age
- 18 years and over
- People
- 123 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT05714839EU 2022-501941-63-00Registry updated 2026-08-19
Phase 3RecruitingTrial-stage medicine
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
- Where
- Ankara, Izmir
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- European Myeloma Network B.V.
See details and how to joinNCT06932562EU 2024-519827-16-00Registry updated 2026-03-25
No phaseRecruitingResearch participation
Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
- Where
- Ankara, Antalya, Istanbul
- Age
- 18 years and over
- People
- 75 worldwide
- Run by
- Takeda
See details and how to joinNCT05879757Registry updated 2026-02-18
All Multiple myeloma trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.